Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 46.44m |
Free float | 46.32m |
P/E (TTM) | 38.01 |
Market cap | 8.90bn USD |
EPS (TTM) | 5.04 USD |
Annual div (ADY) | 1.21 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Nov 15 2024 |
Div pay-date | Dec 16 2024 |
Data delayed at least 15 minutes.
More ▼
- Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
- Teleflex to Present at the Jefferies London Healthcare Conference
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
- First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
- New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
- Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
- Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
- Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
- Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant Procedural Efficiency Compared with Traditional Surgical Staplers
More ▼